ASP Isotopes Inc. Common Stock Total Liabilities
ASP Isotopes Inc. Common Stock total liabilities. Based on the latest financial reports, ASP Isotopes Inc. Common Stock (ASPI) has total liabilities worth $297.26 Million USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check ASPI asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of ASP Isotopes Inc. Common Stock (2021–2025)
Total liabilities of ASP Isotopes Inc. Common Stock from 2021 to 2025. This chart illustrates how ASP Isotopes Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data. Explore ASP Isotopes Inc. Common Stock (ASPI) long-term investment share to see how much of total assets are deployed in long-term investments.
ASP Isotopes Inc. Common Stock Competitors by Total Liabilities
The table below lists competitors of ASP Isotopes Inc. Common Stock ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MFS Intermediate Income Trust
NYSE:MIN
|
USA | $1.67 Million |
|
Itafos Corp
V:IFOS
|
Canada | CA$378.91 Million |
|
Zhejiang Shapuaisi Pharmaceutical Co Ltd
SHG:603168
|
China | CN¥513.25 Million |
|
Zhejiang Baida Precision Mnfg
SHG:603331
|
China | CN¥1.97 Billion |
|
Larvotto Resources Ltd
AU:LRV
|
Australia | AU$162.72 Million |
|
Road Environment Technology Co. Ltd. A
SHG:688156
|
China | CN¥1.03 Billion |
|
FSP Technology Inc
TW:3015
|
Taiwan | NT$5.98 Billion |
|
TruBridge Inc.
NASDAQ:TBRG
|
USA | $219.05 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down ASP Isotopes Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ASP Isotopes Inc. Common Stock asset portfolio.
Liquidity & Leverage Metrics
ASP Isotopes Inc. Common Stock Total Liabilities Ratios Explained
ASP Isotopes Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.87 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.12 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.52 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ASP Isotopes Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ASP Isotopes Inc. Common Stock (2021–2025)
The table below shows the annual total liabilities of ASP Isotopes Inc. Common Stock from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $249.98 Million | +478.91% |
| 2024-12-31 | $43.18 Million | +280.23% |
| 2023-12-31 | $11.36 Million | +323.95% |
| 2022-12-31 | $2.68 Million | +133.96% |
| 2021-12-31 | $1.14 Million | -- |
About ASP Isotopes Inc. Common Stock
ASP Isotopes Inc., a development stage advanced materials company, engages in the production, distribution, marketing, and sale of isotopes in South Africa,Hong Kong, and United States. It operates in two segments, Nuclear Fuels, and Specialist Isotopes and Related Services. The Nuclear Fuels segment focuses on the research and development of technologies and methods used to produce high-assay lo… Read more